Detalhe da pesquisa
1.
Overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study.
Lancet Oncol
; 24(1): 33-44, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36460017
2.
Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 395(10240): 1835-1844, 2020 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32534646
3.
Melatonin and Metformin Failed to Modify the Effect of Dacarbazine in Melanoma.
Oncologist
; 26(5): 364-e734, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33749049
4.
An Open-Label Study of the Safety and Efficacy of Tag-7 Gene-Modified Tumor Cells-Based Vaccine in Patients with Locally Advanced or Metastatic Malignant Melanoma or Renal Cell Cancer.
Oncologist
; 25(9): e1303-e1317, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32240562
5.
Nivolumab in patients with metastatic renal cell carcinoma and chronic hepatitis C virus infection.
Cancer Immunol Immunother
; 69(6): 983-988, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32078017
6.
BRAF-mutated clear cell sarcoma is sensitive to vemurafenib treatment.
Invest New Drugs
; 33(5): 1136-43, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26286452
7.
Novel PD-1 inhibitor prolgolimab: expanding non-resectable/metastatic melanoma therapy choice.
Eur J Cancer
; 149: 222-232, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33872982
8.
Real-World Experience with Targeted Therapy in BRAF Mutant Advanced Melanoma Patients: Results from a Multicenter Retrospective Observational Study Advanced Melanoma in Russia (Experience) (ADMIRE).
Cancers (Basel)
; 13(11)2021 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34064013
9.
Vemurafenib-induced progression of breast cancer: a case report and review of the literature.
Target Oncol
; 11(2): 235-8, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26264150
10.
Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC--A Randomized Phase III Trial.
J Clin Oncol
; 34(5): 443-51, 2016 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26628478
11.
High sensitivity of BRCA1-associated tumors to cisplatin monotherapy: report of two cases.
Cancer Genet Cytogenet
; 197(1): 91-4, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20113845